Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday – Amyris (NASDAQ:AMRS), Cerevel Therapeutics Hldg (NASDAQ:CERE)

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.

• Madrigal Pharmaceuticals, Inc. MDGL shares climbed 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
• Viking Therapeutics, Inc. VKTX shares surged 61% to $6.48 in sympathy with Madrigal Pharmaceuticals which announced a successful trial for liver fibrosis.
• Cerevel Therapeutics Holdings, Inc. CERE rose 24% to $31.53 after the company said its Emraclidine Ambulatory Blood Pressuring Monitoring Trial did not cause an increase in blood pressure.
• CI&T Inc CINT rose 12.8% to $5.89. CI&T said that it has become an Amazon Web Services (AWS) Advanced Tier Services Partner within the AWS Partner Network.
• Reading International, Inc. RDIB gained 10.2% to $19.77.
• Summit Therapeutics Inc. SMMT gained 10% to $3.9699.
• Youdao, Inc. DAO jumped 9.1% to $5.68.
• Perfect Corp. PERF gained 8.4% to $7.10.
• TDCX Inc. TDCX surged 8.3% to $12.12.
• Empire State Realty OP, L.P. ESBA rose 7.4% to $6.66.
• Amyris, Inc. AMRS gained 6.8% to $2.1122 amid the company announcing an amended loan agreement and the purchase of Aprinnova shares for $49M.

Check out this: Ethereum Edges Higher But Remains Below This Key Level; XDC Network Becomes Top Gainer